Synonyms: compound 1 [PMID: 34889605] | MRTX-1133
Compound class:
Synthetic organic
Comment: MRTX1133 is a selective, non-covalent inhibitor of the KRASG12D oncogene [2]. KRASG12D is the most common oncogenic mutation in KRAS mutated cancers. The chemical structure shown here was rendered from the SMILES string provided by Wang et al. in their disclosure paper [2]. Note that this rendering contains additional specified stereo centers compared to PubChem CID 156124857. Anti-tumour efficacy in relevant xenograft models was reported in October 2022 [1].
![]() Ligand Activity Visualisation ChartsThese are box plot that provide a unique visualisation, summarising all the activity data for a ligand taken from ChEMBL and GtoPdb across multiple targets and species. Click on a plot to see the median, interquartile range, low and high data points. A value of zero indicates that no data are available. A separate chart is created for each target, and where possible the algorithm tries to merge ChEMBL and GtoPdb targets by matching them on name and UniProt accession, for each available species. However, please note that inconsistency in naming of targets may lead to data for the same target being reported across multiple charts. ✖ |
|
Download 2D Structure ![]() |
|
Canonical SMILES | Download |
Isomeric SMILES | Download |
InChI standard identifier | Download |
InChI standard key | Download |
Molecular structure representations generated using Open Babel